Health Canada Evaluating Ndma In Metformin Drugs

Metformin Drug Recall Summary Health Canada is investigating the presence of NDMA, a chemical impurity, in metformin medications used to treat type 2 diabetes. The investigation affects metformin products distributed across Canada. Health Canada is currently evaluating whether these products pose a safety concern to patients taking them.

Reason

Product safety

Category

consumer product recall

Country

Canada

Agency

HC-PRODUCTS

Recall date

2019-12-05

Status

Ongoing

Distribution

Canada-wide

Official recall notice from HC-PRODUCTS

Recall details on Nibble Recalls: https://trynibble.app/recalls/b1d53f2c-4b8b-4f83-b70e-8defdd0efb40